These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin. Uchida T; Martin S; Foster TP; Wardley RC; Grimm S Pharm Res; 1994 Jul; 11(7):1009-15. PubMed ID: 7937541 [TBL] [Abstract][Full Text] [Related]
4. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin. Cho SW; Song SH; Choi YW Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588 [TBL] [Abstract][Full Text] [Related]
5. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method. Uchida T; Yagi A; Oda Y; Goto S J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988 [TBL] [Abstract][Full Text] [Related]
6. Controlled release microparticles for vaccine development. O'Hagan DT; Jeffery H; Roberts MJ; McGee JP; Davis SS Vaccine; 1991 Oct; 9(10):768-71. PubMed ID: 1759495 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique. Zhu KJ; Jiang HL; Du XY; Wang J; Xu WX; Liu SF J Microencapsul; 2001; 18(2):247-60. PubMed ID: 11253941 [TBL] [Abstract][Full Text] [Related]
8. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin. Uchida T; Yoshida K; Ninomiya A; Goto S Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1569-73. PubMed ID: 7586084 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Woo BH; Jiang G; Jo YW; DeLuca PP Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769 [TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541 [TBL] [Abstract][Full Text] [Related]
11. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Rosas JE; Hernández RM; Gascón AR; Igartua M; Guzman F; Patarroyo ME; Pedraz JL Vaccine; 2001 Aug; 19(31):4445-51. PubMed ID: 11483270 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens. Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019 [TBL] [Abstract][Full Text] [Related]
13. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition. Kwon YM; Kim SW Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317 [TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Jiang G; Qiu W; DeLuca PP Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968 [TBL] [Abstract][Full Text] [Related]
16. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Uchida T; Yagi A; Oda Y; Nakada Y; Goto S Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042 [TBL] [Abstract][Full Text] [Related]